Ligand Introduces 2019 Financial Outlook and Raises 2018 Financial Guidance
Go back to Ligand Introduces 2019 Financial Outlook and Raises 2018 Financial Guidance| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 284.10 +3.61 (1.29%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $280.49 | 52 Week High | $139.79 | |||
| Open | $276.77 | 52 Week Low | $82.07 | |||
| Day High | $285.90 | P/E | 660.70 | |||
| Day Low | $275.60 | EPS | $0.43 | |||
| Volume | 203,710 | |||||

